Doctor Krisztina Szabo
University of Debrecen, Debrecen (Hungary)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Similar heart failure hospitalization and survival benefits are associated with Sacubitril/Valsartan therapy in CRT non responders and in HFrEF patients with no CRT indication
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Clinical heart failure from diagnostics to treatment
The effectiveness of ARNI medication in patients, non-responder to cardiac resynchronization therapy
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Heart failure pharmacotherapy - Sacubitril/valsartan
ESC 365 is supported by
